Martin, Cerila .
HRN: 22-77-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2023
MUPIROCIN 2%, 15G (TUBE)
03/21/2023
03/28/2023
INTRAVENOUS
2%
BID
Multiple Soft Tissue Injuries
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes